TGFB1 and cancer: We characterised the most frequently mutated known cancer pathways (ATM, p53, Wnt/β-catenin, ERBB, PTEN, PI3K/AKT, ERK/MAPK, and TGF-β) in tumour pairs (Supplementary Table 5).